adenine has been researched along with Fungal Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 6 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MR | 1 |
| Thompson, GR | 1 |
| Patterson, TF | 1 |
| Luppi, M | 1 |
| Forghieri, F | 1 |
| Potenza, L | 1 |
| Anastasopoulou, A | 1 |
| DiPippo, AJ | 2 |
| Kontoyiannis, DP | 2 |
| Frei, M | 1 |
| Aitken, SL | 1 |
| Jain, N | 1 |
| Thompson, P | 1 |
| Wierda, W | 1 |
| Reynolds, G | 1 |
| Slavin, M | 1 |
| Teh, BW | 2 |
| Kaloyannidis, P | 1 |
| Ayyad, A | 1 |
| Bahaliwah, Z | 1 |
| Blowi, B | 1 |
| Alanazi, W | 1 |
| Al Shammasi, Z | 1 |
| Elsoudi, H | 1 |
| Ibrahim, I | 1 |
| Al Hashmi, H | 1 |
| Chui, W | 1 |
| Handunnetti, S | 1 |
| Tam, C | 1 |
| Worth, LJ | 1 |
| Thursky, KA | 1 |
| Slavin, MA | 1 |
| Kabbage, M | 1 |
| Williams, B | 1 |
| Dickman, MB | 1 |
2 reviews available for adenine and Fungal Diseases
| Article | Year |
|---|---|
Fungal Infections Potentiated by Biologics.
Topics: Adenine; Antigens, CD; Biological Products; Clinical Trials as Topic; Humans; Mycoses; Piperidines; | 2020 |
Non-Aspergillus invasive mould infections in patients treated with ibrutinib.
Topics: Adenine; Aged; Anticarcinogenic Agents; Antifungal Agents; Aspergillosis; Aspergillus; Female; Fungi | 2020 |
6 other studies available for adenine and Fungal Diseases
| Article | Year |
|---|---|
Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity.
Topics: Adenine; B-Lymphocytes; Consensus; Humans; Immunosuppressive Agents; Mycoses; Neoplasms; Piperidines | 2020 |
Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinib.
Topics: Adenine; Humans; Incidence; Leukemia, Lymphocytic, Chronic, B-Cell; Mycoses; Piperidines; Pyrazoles | 2020 |
Ibrutinib and invasive fungal infections: the known, the unknown and the known unknowns.
Topics: Adenine; Humans; Incidence; Invasive Fungal Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Myco | 2020 |
Ibrutinib for steroid refractory chronic graft-versus-host disease: therapeutic efficiency can be limited by increased risk of fungal infection.
Topics: Adenine; Chronic Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; My | 2021 |
High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia.
Topics: Adenine; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; My | 2019 |
Cell death control: the interplay of apoptosis and autophagy in the pathogenicity of Sclerotinia sclerotiorum.
Topics: Adenine; Androstadienes; Antifungal Agents; Apoptosis; Arabidopsis; Ascomycota; Autophagy; Chloroqui | 2013 |